These encouraging in vitro results with NT431 (Figure 3 and Figure 4) demonstrated high CDK4/6 inhibition in kinase activity assay combined with high efficacy against various cancer cell lines warranting the radiosynthesis of [18F]NT431 and the subsequent in vivo evaluation. This evidence concerns the gene CDK4 and cancer.